Gastrointestinal Oncology Department 1

<Specialty Overview>

According to the hospital's discipline development plan and overall layout, and combining the technical characteristics of the professional staff, the diagnostic and treatment direction of Gastrointestinal Oncology Department 1 is the diagnosis and treatment of common and rare difficult tumors of the digestive system. The department has inherited and carried forward the fine tradition of medical oncology and, with first-class staff quality, first-class medical equipment and first-class technical strength, has become a professional department for the standardized treatment of digestive system malignancies.

Gastrointestinal Oncology Department 1 currently has 6 physicians, of whom 2 are chief physicians, 1 is an associate chief physician and 3 are attending physicians; 3 hold doctoral degrees and 3 hold postgraduate degrees. Every physician has teaching qualifications, including 1 doctoral supervisor and 2 master's supervisors.

<Specialty Scope of Diagnosis and Treatment>

Diagnosis and treatment of malignancies of the digestive system, including common and rare difficult tumors such as esophageal cancer, gastric cancer, small intestinal cancer, colorectal cancer, pancreatic cancer, liver cancer and biliary system tumors.

<Specialty Technical Features>

Gastrointestinal Oncology Department 1 is a national clinical trial research institution for new anti-tumor drugs and a category-III (Class 3) medical technology training institution. It routinely carries out comprehensive tumor treatment including chemotherapy, molecular targeted therapy, gene therapy, biological immunotherapy, radiotherapy and physical minimally invasive therapy, and has established a multidisciplinary diagnosis and treatment (MDT) team for digestive tumors, emphasizing the combination of systemic drug treatment and minimally invasive tumor treatment; it holds a leading and guiding position in the anti-tumor cause in the city, the Liaonan region and even the whole province, and its influence in the national oncology community keeps rising. According to tumor diagnosis and treatment standards and guidelines issued by the National Health and Family Planning Commission or recognized by the industry (CSCO guidelines, NCCN guidelines, ESMO guidelines, etc.), evidence-based medicine and frontier progress in diagnosis and treatment, the department formulates the diagnostic and treatment courses, technical operating standards and clinical pathways for digestive system tumors of this specialty. In close cooperation with the pharmacy department and the nutrition department, it carries out timely standardized treatment of cancer pain and nutritional support for tumor patients. It regularly carries out publicity and education on tumor screening and early intervention, and provides patients with detailed guidance on tumor rehabilitation, efficacy evaluation plans and follow-up. It strengthens communication with tumor patients and does a good job of psychological counseling, education and explanation.

The main featured diagnostic and treatment technologies are: precision treatment based on molecular detection technology; thermal (heat) treatment technology combining drug therapy (chemotherapy, targeted therapy and immunotherapy) with deep hyperthermia; local interventional treatment and radiofrequency treatment on the basis of systemic treatment; individualized treatment under the multidisciplinary diagnosis and treatment model, etc., all of which are in a leading position in China.

<Specialty Scientific Research and Teaching Work>

Research: It undertakes 3 provincial-level scientific fund projects. More than 40 papers have been published, including more than 10 SCI papers.

Teaching: It undertakes the teaching of undergraduate, master's and doctoral students and trainee physicians, emphasizing teaching in accordance with aptitude and clinical competence training, and has trained nearly 50 doctoral and master's graduate students.

<Goals and Philosophy>

The department is committed to the standardized and individualized diagnosis and treatment of digestive system tumors, consolidates the multidisciplinary tumor treatment team, strengthens domestic and international academic exchanges and cooperation, actively participates in domestic and international clinical research, integrates medical resources, expands its academic radiation capacity, increases research investment, applies for high-quality research and translational medicine projects, promotes biomarker-guided individualized precision diagnosis and treatment, provides high-quality medical care for patients, and improves patients' quality of life and survival time.